According to GuruFocus Insider Data, these are the largest CEO buys during the past week.
OPKO Health CEO bought 263,000 shares
OPKO Health Inc. (OPK, Financial) CEO, Chairman, and 10% owner Phillip Frost bought 263,000 shares during the past week at a price of $4.21.
OPKO is a diversified health care company. Its business includes diagnostics and provision of pharmaceutical products. The company has a market cap of $2.17 billion. Its shares traded at $3.88 as of Feb. 9.
Net loss in thousands for the three months ended Sept. 30, 2017, was $46.44 million compared to $14.98 million for the prior-year period.
Frost bought 55,000 shares on Feb. 2 at a price of $4.3; 50,000 shares on Feb. 5 at a price of $4.14; 60,000 shares on Feb. 6 at a price of $4.22; 78,000 shares on Feb. 7 at a price of $4.22; and 20,000 shares on Feb. 8 at a price of $4.04. The price of the stock has decreased by 3.96% since.
The Brink's CEO bought 10,000 shares
The Brink's Co. (BCO, Financial) President and CEO Douglas A. Pertz bought 10,000 shares on Feb. 8 at a price of $72.91. The price of the stock has increased by 4.17% since.
Brink's, along with its subsidiaries, provides secure logistics and security solutions including cash-in-transit, ATM replenishment and maintenance, cash management services, including vault outsourcing, money processing and intelligent safe services. The company has a market cap of $3.83 billion. Its shares traded at $75.95 with a P/E ratio of 230.15 as of Feb. 9.
Net income (loss) for the fourth quarter of 2017 was $52.1 million compared to $12.8 million for the prior-year period.
Executive Vice President and Chief Financial Officer Ronald James Domanico bought 3,500 shares on Feb. 8 at a price of $72.18. The price of the stock has increased by 5.22% since.
FS Investment CEO bought 84,458 shares
FS Investment Corp. (FSIC, Financial) CEO Michael C. Forman bought 84,458 shares during the past week at a price of $7.40.
FS Investment is an investment company. Its business objective is to achieve long-term capital appreciation and income by investing in a diverse range of sectors such as capital goods, apparels and financial services. The company has a market cap of $1.78 billion. Its shares traded at $7.25 with a price-earnings (P/E) ratio of 8.10 as of Feb. 9.
Net investment income for the third quarter of 2017 was $50.648 million compared to $49.0 million for the prior-year period.
Forman bought 17,158 shares on Feb. 5 at a price of $7.44; 33,500 shares on Feb. 7 at a price of $7.45; and 33,800 shares on Feb. 9 at a price of $7.33. The price of the stock has decreased by 1.09% since.
Director Michael Heller bought 600 shares on Feb. 5 at a price of $7.25 and 10,900 shares on Feb. 6 at a price of $7.14. The price of the stock has increased by 1.54% since.
Executive Vice President Zachary Klehr bought 2,000 shares on Feb. 5 at a price of $7.25. The price of the stock has decreased by 0% since.
Athenex CEO bought 20,000 shares
Athenex Inc. (ATNX, Financial) CEO and Chairman of the Board Johnson Yiu Nam Lau bought 20,000 shares on Feb. 8 at a price of $14.40. The price of the stock has decreased by 1.94% since.
Athenex is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. The company has a market cap of $879.61 million. Its shares traded at $14.12 as of Feb. 9.
Revenue for the three months ended September 30, 2017 was $14.0 million, an increase of $8.4 million, or 149%, as compared to $5.6 million for the three months ended September 30, 2016.
On Jan. 25, 2018 Athenex announced a public offering of 4,300,000 shares of its common stock at a public offering price of $15.25 per share, before underwriting discounts and commissions.
Director Jinn Wu bought 10,000 shares on Feb. 9 at a price of $13.64. The price of the stock has increased by 3.52% since.
Director Manson Fok bought 50,000 shares on Feb. 8 at a price of $14.36. The price of the stock has decreased by 1.67% since.
Prestige Brands Holdings CEO bought 7,000 shares
Prestige Brands Holdings Inc. (PBH, Financial) CEO Ronald M. Lombardi bought 7,000 shares on Feb. 5 at a price of $35.94. The price of the stock has decreased by 6.07% since.
Prestige Brands Holdings is a healthcare company. Its core business involves the distribution of healthcare and household cleaning products to supermarkets and drug stores. The company has a market cap of $1.79 billion. Its shares traded at $33.76 with a price-earnings (P/E) ratio of 4.63.
Reported net income for the third quarter of fiscal 2018 was $314.8 million compared to the prior year period’s net income of $31.6 million.
Director Natale S. Ricciardi bought 3,000 shares on Feb. 7 at a price of $37.04. The price of the stock has decreased by 8.86% since.
Director Gary E. Costley bought 7,500 shares on Feb. 5 at a price of $35.47. The price of the stock has decreased by 4.82% since.
Director James M. Jenness bought 4,200 shares on Feb. 5 at a price of $35.47. The price of the stock has decreased by 4.82% since.
For the complete list of stocks that bought by their company CEOs, go to: CEO Buys.
Disclosure: I do not own stock in any of the companies mentioned in the article.
